AIDS researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases. The study, published today in PLoS ONE, demonstrates that human stem cells can be engineered into the equivalent of a genetic vaccine.
By Taking CD8 cytotoxic T lymphocytes — the "killer" T cells that help fight infection — from an HIV-infected individual, the researchers identified the molecule known as the T-cell receptor, which guides the T cell in recognizing and killing HIV-infected cells.
These cells, while able to destroy HIV-infected cells, do not exist in enough quantities to clear the virus from the body. So the researchers cloned the receptor and genetically engineered human blood stem cells, then placed the stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.
The engineered stem cells developed into a large population of mature, multifunctional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. The researchers also found that HIV-specific T-cell receptors have to be matched to an individual in much the same way that an organ is matched to a transplant patient.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at UCLA.
"These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
The next step is to test this strategy in a more advanced model to determine if it would work in the human body, said co-author Jerome A. Zack, UCLA professor of medicine in the division of hematology and oncology and associate director of the UCLA AIDS Institute. The researchers also hope to expand the range of viruses against which this approach could be used.
Citation: Kitchen SG, Bennett M, Galić Z, Kim J, Xu Q, et al., 'Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice', PLoS ONE 2009, 4(12): e8208. doi:10.1371/journal.pone.0008208
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- War On Doping And The Hypocritical Treatment Of Lance Armstrong
- Quantum Cryptography Core Question At The Heart Of Quantum Information Theory Answered?!?
- How Marijuana Use Affects People With Bipolar Disorder
- Unregulated Genetic Testing Websites Still Causing Concerns
- What Antidepressants Do To Healthy People
- Ignorance of math and physics is no excuse
- The New York Times On Drugs - Wrong, Naive Or Misleading?
- "narcotics do not stop working after three monthsAh - come on, don't you know that those heroine..."
- "Let me explain exactly why you or your family member reacted as they did, why the test subjects..."
- "One guy runs a red light and is stopped and confesses. One guy runs a red light and says he didn't..."
- "To the author: Before you write a story and assert that the treatment of Lance Armstrong was hypocritical..."
- "Above the author writes: Leipheimer was only banned for six months, and out of season so he did..."
- Antidepressants linked to improved cardiovascular outcomes
- Bee Bailout: If dollars rule the world, why shouldn't bees be too big to fail?
- Antidepressants linked with improved cardiovascular outcomes
- How healthy is genetically modified soybean oil?
- Healthier males help infertile obese females conceive